From: Myostatin and markers of bone metabolism in dermatomyositis
DM patients n = 20 | Control group n = 20/ Normative values | |
---|---|---|
Age | 66 [55; 76] | 61 [56; 68] |
BMI | 26 [23; 30] | 26 [23; 30] |
Disease duration | 6.5 [4.25; 12.5] | – |
Treatment | ||
GC alone | 4 | – |
GC + immunosuppressionc | 4 | – |
IVIG alone | 2 | – |
IVIG+GC/±immunosuppressiond | 5 | – |
IVIG+immunosuppressiond | 5 | – |
CRP [mg/dl] | 0.3 [0.1; 0.6] | < 0.5a |
CK [U/l] | 133 [63; 173] | < 170a |
Aldolase [U/l] | 3.8 [2.5; 5.4] | 0–7.6a |
Ca [mmol/l] | 2.3 [2.3; 2.4] | 2.4 [2.3; 2.6]b |
Phosphate [mmol/l] | 1.04 [0.94; 1.19] | 1.20 [1.08; 1.51]b |
Creatinine [mg/dl] | 0.74 [0.64; 0.87] | 0.86 [0.79; 1.01]b |
PTH [pg/ml] | 43.2 [33.0; 69.5] | 36.0 [15.7; 44.9] |
25OHD [nmol/l] | 66.7 [50.4; 87.0] | 40.7 [26.0; 59.5]b |
BAP [U/l] | 8.8 [5.9; 12.4] | 5.2–24.4a |
OC [ng/ml] | 18.8 [10.0; 27.8] | 22.3 [15.1; 32.0] |
P1NP [ng/ml] | 42.0 [29.5; 80.5] | 37.7 [28.8; 74.5] |
CTX [ng/ml] | 0.22 [0.11; 0.50] | 0.22 [0.15; 0.33] |